Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Mean amplitude of glycemic excursion"'
Autor:
Nikita Shah, Jugal V Gada, Vishwanath S Billa, Jatin Piyush Kothari, Shrirang D Bichu, Deepa H Usulumarty, Suhas S Khaire, Premlata K Varthakavi, Nikhil M Bhagwat
Publikováno v:
Indian Journal of Endocrinology and Metabolism, Vol 26, Iss 5, Pp 439-445 (2022)
Context: Glycemic variability plays a major role in the development as well as the progression of cardiovascular disease in diabetes. Aims: We compared the mean plasma glucose and glycemic variability (GV) parameters on and off hemodialysis (HD) in p
Externí odkaz:
https://doaj.org/article/9ab84fcf6e574d3a858795e6883f2b01
Autor:
Shangyu Chai, Ruya Zhang, Ye Zhang, Richard David Carr, Yiman Zheng, Swapnil Rajpathak, Miao Yu
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
ObjectiveThe influence of dipeptidyl peptidase-4 (DPP4) inhibitors on glycemic variability compared to other oral antidiabetic drugs (OADs), measured based on the mean amplitude of glycemic excursions (MAGE), has not been comprehensively analyzed. Th
Externí odkaz:
https://doaj.org/article/6bcd12bbc9614583b21c904d1d8cd56a
Autor:
Hiroyuki Yamamoto, Akihide Konishi, Toshiro Shinke, Hiromasa Otake, Masaru Kuroda, Tsuyoshi Osue, Takahiro Sawada, Tomofumi Takaya, Hiroya Kawai, Naoko Hashimoto, Takeshi Ohara, Yushi Hirota, Kazuhiko Sakaguchi, Takashi Omori, Wataru Ogawa, Ken-ichi Hirata
Publikováno v:
BMC Cardiovascular Disorders, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background The impact of reduction in glycemic excursion on coronary plaques remains unknown. This study aimed to elucidate whether a dipeptidyl peptidase 4 inhibitor could reduce the glycemic excursion and stabilize the coronary plaques com
Externí odkaz:
https://doaj.org/article/cc7c6fb688404bea9ac1771daeb0cf9b
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Kentaro Kakuta, Kaoru Dohi, Miho Miyoshi, Takashi Yamanaka, Masaki Kawamura, Jun Masuda, Tairo Kurita, Toru Ogura, Norikazu Yamada, Yasuhiro Sumida, Masaaki Ito
Publikováno v:
Cardiovascular Diabetology, Vol 16, Iss 1, Pp 1-14 (2017)
Abstract Background Both the progression of diabetic kidney disease and increased glycemic variability play important roles in the pathogenesis of coronary plaque formation via inflammatory pathways in patients with type 2 diabetes mellitus (T2DM). T
Externí odkaz:
https://doaj.org/article/62cc13f4bfcb4fc79197fb80b2851d89
Publikováno v:
Clinical Management Issues, Vol 4, Iss 4, Pp 131-135 (2010)
Diabetes is characterised by development of specific microvascular complications and by a high incidence of accelerated atherosclerosis. Several Authors demonstrated that post-prandial hyperglycaemia is certainly an independent risk factor of vascula
Externí odkaz:
https://doaj.org/article/946847a56dd54538a10c5750a45e04bb
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Wataru Ogawa, Takeshi Ohara, Akihide Konishi, Toshiro Shinke, Masaru Kuroda, Tsuyoshi Osue, Hiromasa Otake, Takahiro Sawada, Ken-ichi Hirata, Kazuhiko Sakaguchi, Hiroyuki Yamamoto, Takashi Omori, Yushi Hirota, Naoko Hashimoto, Tomofumi Takaya, Hiroya Kawai
Publikováno v:
BMC Cardiovascular Disorders, Vol 21, Iss 1, Pp 1-9 (2021)
BMC Cardiovascular Disorders
BMC Cardiovascular Disorders
Background The impact of reduction in glycemic excursion on coronary plaques remains unknown. This study aimed to elucidate whether a dipeptidyl peptidase 4 inhibitor could reduce the glycemic excursion and stabilize the coronary plaques compared wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42e7776fec627069551d144ac385db83
https://doi.org/10.1186/s12872-021-01902-0
https://doi.org/10.1186/s12872-021-01902-0
Chronic hyperglycemia and acute glucose fluctuations are the two main factors that trigger complications in diabetes mellitus (DM). Continuous and sustainable observation of these factors is significant to be done to reduce the potential of cardiovas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42cfcf9f75ce9d18ed1c8e5cfd1e7c75
https://zenodo.org/record/4381075
https://zenodo.org/record/4381075
Autor:
Mussa H. Almalki, Bader Alzahrani, Naji Aljuhani, Shawana Abdulhamid Khan, Souha S Elabd, Anwar A. Jammah, Saad Alzahrani, Badurudeen Mahmood Buhary
Publikováno v:
Clinical Medicine Insights. Endocrinology and Diabetes
Clinical Medicine Insights: Endocrinology and Diabetes, Vol 14 (2021)
Clinical Medicine Insights: Endocrinology and Diabetes, Vol 14 (2021)
Background: Glucose variability (GV) is a common and challenging clinical entity in the management of people with type 1 diabetes (T1DM). The magnitude of GV in Saudi people with T1DM was not addressed before. Therefore, we aimed to study GV in a con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a427f74cd27e61038f58429c0e350354
https://pubmed.ncbi.nlm.nih.gov/34017209
https://pubmed.ncbi.nlm.nih.gov/34017209